⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2007360 | 0.75 | — | — | |
| SCHEMBL2273988 | 0.75 | — | — | |
| SCHEMBL21316492 | 0.75 | — | — | |
| SCHEMBL7993653 | 0.75 | — | — | |
| SCHEMBL28757454 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL7587143 | 0.73 | PTGS2 (0.52) | — | |
| SCHEMBL1606996 | 0.72 | ALDH1A1 (0.31) | — | |
| SCHEMBL22807643 | 0.70 | — | — | |
| SCHEMBL517063 | 0.70 | — | — | |
| SCHEMBL28779289 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2178869-B1 | INDOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD (KR) | 2013-06-12 | — | — | EP | claimed |
| WO-2007038387-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRUSES AND CANCER | YALE UNIVERSITY (US) | 2007-04-05 | — | — | WO | claimed |
| EP-4329889-A1 | IL4I1 INHIBITORS AND METHODS OF USE | Merck Sharp & Dohme LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2022232333-A1 | IL4I1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2022-11-03 | — | — | WO | disclosed |
| EP-3002283-B1 | THIAZOLE DERIVATIVES | KYOWA HAKKO KIRIN CO LTD (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-8092661-B2 | Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin | BIOMERIEUX (FR) | 2012-01-10 | — | — | US | disclosed |
| US-7812180-B2 | Electropolymerisable monomers that are soluble in aqueous solution and electroactive probes that can be obtained with such monomers | BIOMERIEUX (FR) | 2010-10-12 | — | — | US | disclosed |
| US-20100184909-A1 | CROSSLINKABLE POLYMERS WITH HETEROAROMATIC GROUPS | HENKEL AG & CO. KGAA (DE) | 2010-07-22 | — | — | US | disclosed |
| EP-2195353-A1 | CROSSLINKABLE POLYMERS WITH HETEROAROMATIC GROUPS | Henkel AG & Co. KGaA (DE) | 2010-06-16 | — | — | EP | disclosed |
| US-20090314660-A1 | Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin | BIOMERIEUX (FR) | 2009-12-24 | — | — | US | disclosed |
| WO-2009043655-A1 | CROSSLINKABLE POLYMERS WITH HETEROAROMATIC GROUPS | HENKEL AG & CO. KGAA (DE) | 2009-04-09 | — | — | WO | disclosed |
| WO-2006077424-A1 | PHARMACEUTICAL COMPOUNDS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-07-27 | — | — | WO | disclosed |
| EP-1578759-A1 | PYRROLES SUBSTITUTED BY OLIGONUCLEOTIDES | BIOMERIEUX SA (FR) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004060904-A1 | PYRROLES SUBSTITUTED BY OLIGONUCLEOTIDES | BIOMERIEUX SA (FR) | 2004-07-22 | — | — | WO | disclosed |
| US-5652247-A | VASOPRESSIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD (JP) | 1997-07-29 | — | — | US | disclosed |
| US-5436254-A | Vaopressin antagonists | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |